Status:
COMPLETED
Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors
Lead Sponsor:
New Mexico Cancer Research Alliance
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The use of performance status and LDH in combination can predict patient survival more accurately than physician clinical impression or the patients' own feelings about their survival
Detailed Description
Patients with incurable cancer frequently ask their doctors for an estimate of survival. Such estimates can assist patients in making decisions about how best to spend their time and energy. Survival ...
Eligibility Criteria
Inclusion
- All patients must be at least 18 years of age
- All patients must have documented incurable metastatic cancer
- All patients must have exhausted any treatments which are known to prolong survival in their disease, or have elected not to receive further life-prolonging therapy. Specifically, patients with the following are eligible:
- Non-small cell lung cancer patients after third systemic therapy
- Small cell lung cancer patients after second systemic therapy
- Breast cancer patients after third cytotoxic therapy (does not include hormonal therapy)
- Colorectal cancer patients after second systemic therapy
- Hormone refractory prostate cancer patients after first cytotoxic therapy
- Cancer of unknown primary
- Pancreatic cancer patients after first systemic therapy
- The use of systemic (chemotherapy, immunotherapy) or local treatments (XRT) for palliation of symptoms is allowed
- Patients with a history of previous cancers are allowed
- Patients with a history of other significant disease (e.g. heart disease, COPD, etc.) are allowed
- All patients must sign informed consent
Exclusion
- Patients with acute or chronic leukemia, Hodgkin's disease, or non-Hodgkins lymphoma are excluded
- Patients who do not sign informed consent are excluded
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00322634
Start Date
February 1 2006
End Date
July 1 2011
Last Update
September 19 2012
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hematology Oncology Associates
Albuquerque, New Mexico, United States, 87102-3661
2
Radiation Oncology Associates
Albuquerque, New Mexico, United States, 87111
3
University of New Mexico
Albuquerque, New Mexico, United States, 87131
4
New Mexico Cancer Care Associates
Santa Fe, New Mexico, United States, 87505